PICCINNI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 4.265
AS - Asia 3.618
EU - Europa 3.569
AF - Africa 247
SA - Sud America 228
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.937
Nazione #
US - Stati Uniti d'America 4.218
IT - Italia 1.036
VN - Vietnam 972
SG - Singapore 944
CN - Cina 823
GB - Regno Unito 809
DE - Germania 453
HK - Hong Kong 378
SE - Svezia 324
FR - Francia 218
IN - India 184
RU - Federazione Russa 182
BR - Brasile 165
UA - Ucraina 147
IE - Irlanda 112
JP - Giappone 90
ZA - Sudafrica 83
CI - Costa d'Avorio 78
NL - Olanda 65
EE - Estonia 56
FI - Finlandia 45
TG - Togo 42
PH - Filippine 31
BE - Belgio 30
AR - Argentina 29
CA - Canada 29
JO - Giordania 23
TW - Taiwan 22
TH - Thailandia 21
AT - Austria 18
ID - Indonesia 14
KR - Corea 14
BD - Bangladesh 13
CH - Svizzera 13
NG - Nigeria 13
PK - Pakistan 13
MX - Messico 12
SA - Arabia Saudita 11
SC - Seychelles 11
PL - Polonia 10
TR - Turchia 10
UZ - Uzbekistan 10
CO - Colombia 9
HR - Croazia 9
IQ - Iraq 9
EC - Ecuador 8
LB - Libano 8
GR - Grecia 7
LT - Lituania 7
AU - Australia 6
CL - Cile 5
ES - Italia 5
IR - Iran 5
KE - Kenya 5
PY - Paraguay 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
MA - Marocco 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
EG - Egitto 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
JM - Giamaica 2
LY - Libia 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
MV - Maldive 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SO - Somalia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
VG - Isole Vergini Britanniche 1
Totale 11.937
Città #
Southend 701
Singapore 595
Ashburn 366
Chandler 361
Hong Kong 347
Fairfield 338
Santa Clara 315
Ho Chi Minh City 234
Dong Ket 199
Wilmington 197
Princeton 193
San Jose 192
Hanoi 155
Ann Arbor 150
Woodbridge 147
Houston 144
Seattle 115
Beijing 112
Dublin 107
Cambridge 98
Los Angeles 94
Bologna 91
Boardman 86
Jacksonville 86
Lauterbourg 85
Dallas 80
Abidjan 78
Nanjing 78
Westminster 78
Padova 75
Rome 72
Tokyo 66
Medford 48
Milan 46
Shenyang 43
Helsinki 42
Lomé 42
Saint Petersburg 39
Buffalo 38
Berlin 35
Bremen 34
Dearborn 34
Mülheim 33
Brussels 28
Changsha 27
Nanchang 27
Da Nang 26
Frankfurt am Main 26
Jinan 26
Redwood City 26
New York 24
Amman 23
Olalla 23
San Diego 23
Redondo Beach 22
Guangzhou 21
Hebei 21
San Venanzo 21
Hefei 20
Shanghai 20
Turin 20
The Dalles 19
Florence 17
Munich 17
Palermo 17
Tianjin 17
Zhengzhou 17
Bari 16
Council Bluffs 16
Haiphong 16
Falls Church 15
Hangzhou 15
Haikou 14
Taipei 14
Abeokuta 13
London 13
Phoenix 13
Bangkok 12
Kunming 12
Norwalk 12
Toronto 12
Biella 11
Biên Hòa 11
Jiaxing 11
Ningbo 11
São Paulo 11
Yubileyny 11
Chicago 10
Lanzhou 10
Messina 10
Hải Dương 9
Naples 9
Redmond 9
Torino 9
Trieste 9
Bühl 8
Chengdu 8
Ferrero 8
Fuzhou 8
Nuremberg 8
Totale 7.371
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 565
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 295
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 271
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 269
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 255
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 245
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 221
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 215
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 197
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 195
Social and clinical descriptors of antipsychotic prescription 194
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 193
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 187
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 187
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 186
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 185
Determinanti demografici, clinici ed organizzativi dell'aderenza alla poli-terapia dopo infarto miocardico acuto 183
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 182
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 181
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 180
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 179
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 178
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 165
Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction 162
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 161
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 160
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 155
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 154
Aderenza al trattamento con Bifosfonati: studio di coorte retrospettivo su database amministrativi dell’Emilia Romagna 153
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 152
Profili di utilizzo dei farmaci antipsicotici nei centri salute mentale della AUSL di Bologna: determinanti clinici e sociali 151
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 149
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 148
Determinanti demografici, clinici ed organizzativi dell’aderenza alla poli-terapia dopo infarto miocardico acuto 145
Infarto del miocardio, edema maculare e fratture associate ai glitazoni: analisi del database di segnalazione spontanea FDA_AERS 144
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 144
Prescription patterns of oral bisphosphonates in Italian patients with osteoporosis 143
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 142
Pioglitazone-associated bladder cancer: the contribution of spontaneous reporting analysis on the basis of FDA_AERS database 139
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 139
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 139
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 139
Impact of notoriety bias on reporting of pancreatitis with antidiabetics: the case of exenatide 136
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 134
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 134
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 133
Burden of community-acquired pneumonia in Italian general practice 128
A project for monitoring disease modifying drug prescriptions for multiple sclerosis in Emilia Romagna 127
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 127
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence 127
Psychiatrists’ Use of Shared Decision Making in the Treatment of Psychosis: The “Farmaci and Famiglie” Project in Bologna 126
Aderenza alla terapia antidepressiva in Emilia-Romagna 123
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 122
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 122
Natalizumab: a country-based surveillance program 121
Progetto europeo di confronto dell'uso dei farmaci 119
Three years of experience: the Italian registry and safety data update 119
The key role of patient in the antipsychotic therapy: shared decision making, adherence and research 119
La rimborsabilità di memantina - il trilemma di Münchausen 118
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database. 116
Glucagon-like peptide 1-based drugs and pancreatic safety. 112
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 112
I rapporti tra medici, pazienti e familiari nella scelta delle terapie farmacologiche dei disturbi psichici: un’indagine presso il dipartimento di salute mentale della AUSL di Bologna 109
The Italian Surveillance Program on Natalizumab 107
Monitoring the use of disease-modifying drugs in multiple sclerosis 107
Healthcare of patients with immunoglobulin A nephropathy through a retrospective observational study of Italian administrative data 106
L’uso dei farmaci in Italia. Rapporto nazionale anno 2011 102
Lack of adherence to oral bisphosphonates in Italian patients: prevalence and predictors 100
Drug-induced Progressive Multifocal Leukoencephalopathy: data mining of international spontaneous ADR report databases 99
VII Report Health Search Anno 2011/2012 99
Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions 99
Drug-related Progressive Multifocal Leukoencephalopathy (PML): datamining of FDA_AERS (Adverse Event Reporting System) 98
Factors Influencing the Disproportional Association Between Triptans and Cerebrovascular Events Within the FDA_AERS Database: Causal Association or Reporting Bias? 98
Prescrizione di Entacapone nella Regione Emilia-Romagna 96
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 96
The Italian Natalizumab Registry: a 1-year follow-up 95
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 94
Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases 82
Use of disease-modifying drugs for multiple sclerosis in neurological centres of Emilia Romagna 82
Drug utilisation of antidepressants in Generai Practice: choice of drugs and adherence in an Italian region 75
Totale 12.146
Categoria #
all - tutte 29.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021459 0 0 0 0 0 0 0 0 0 47 58 354
2021/20221.466 153 66 69 105 127 93 28 87 45 98 356 239
2022/20231.598 195 199 116 212 88 116 40 108 261 64 142 57
2023/2024563 44 79 38 70 57 50 38 31 25 46 58 27
2024/20251.616 99 239 110 116 421 107 86 48 21 74 32 263
2025/20263.407 194 290 368 188 457 216 622 129 654 289 0 0
Totale 12.146